Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Ahmad S. S. Alrashah"'
Autor:
Abdulmajeed M. Jali, Mohammad Firoz Alam, Ali Hanbashi, Wedad Mawkili, Basher M. Abdlasaed, Saeed Alshahrani, Abdullah M. Qahl, Ahmad S. S. Alrashah, Hamad Al Shahi
Publikováno v:
Biomedicines, Vol 11, Iss 12, p 3238 (2023)
Cyclophosphamide, an alkylating agent integral to specific cancer chemotherapy protocols, is often curtailed in application owing to its significant hepatotoxic side effects. Therefore, this study was conducted to assess the hepatoprotective potentia
Externí odkaz:
https://doaj.org/article/95e156421f5d4e5a93d2cae9df9094cb
Autor:
Qahl, Marwa M. Qadri, Mohammad Firoz Alam, Zenat A. Khired, Reem O. Alaqi, Amani A. Khardali, Moudi M. Alasmari, Ahmad S. S. Alrashah, Hisham M. A. Muzafar, Abdullah M.
Publikováno v:
International Journal of Molecular Sciences; Volume 24; Issue 13; Pages: 10621
Chemotherapy-induced kidney damage is an emerging problem that restricts cancer treatment effectiveness. The proteasome inhibitor carfilzomib (CFZ) is primarily used to treat multiple myeloma and has been associated with severe renal injury in humans
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::61d317b8292a6199b2281f72c51f3040